LeMaitre Vascular, Inc. (LMAT) Q4 2020 Earnings Results

Lemaitre Vascular (LMAT) Beats on EPS, Stock Down 2.56%

Lemaitre Vascular's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 2.56% in reaction, likely due to the lack of revenue details and guidance. Investors may be concerned about the absence of forward-looking statements in a challenging market environment.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.34	N/A	+11.48%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed a cautious optimism about the company's performance. They emphasized the importance of maintaining product quality and customer relationships.

Management highlighted the resilience of their product demand despite market challenges.

They noted ongoing investments in innovation to drive future growth.

Lemaitre Vascular (LMAT) Beats on EPS, Stock Down 2.56%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular (LMAT) Beats on EPS, Stock Down 2.56%

Key numbers

Management commentary